肺癌筛查CT上冠状动脉钙化的报告与结局
该回顾性研究评估了肺癌筛查CT中对冠状动脉钙化的真实世界报告准确性及其对下游检查和他汀处方的影响。报告钙化(尤其带S修饰符)与他汀新处方(OR 1.8和4.4)及后续负荷试验(9%)相关。
要点
- 肺癌筛查CT常漏报或低估冠状动脉钙化,配对心脏CT中仅56%评分一致。
- 报告钙化可促使他汀新处方,带S修饰符时OR达4.4。
- 带S修饰符的钙化报告导致9%患者接受后续负荷试验。
关键影像表现/征象
- 肺癌筛查CT与配对心脏CT钙化评分一致者65/117(56%)。
- 肺癌筛查CT未提及或低估钙化者40/117(34%)。
诊断标准与关键数值
- 报告无S修饰符的钙化与他汀新处方OR为1.8。
- 报告带S修饰符的钙化与他汀新处方OR为4.4。
- 带S修饰符的钙化报告后141/1582(9%)患者接受后续负荷试验。
临床应用与阅片要点
- 阅片时应主动评估并报告冠状动脉钙化,避免漏报或低估。
- 对显著钙化可考虑使用S修饰符,以提示临床进行风险获益讨论。
局限性
- 回顾性研究设计。
- 仅117例有配对心脏CT用于评分准确性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the accuracy and downstream testing and statin prescribing of real-world reporting of coronary calcification on lung cancer screening (LCS) CT.
MATERIALS AND METHODS: We retrospectively reviewed LCS CTs from January 2015 to November 2021 for reporting of coronary calcification; reports that denoted coronary calcification as a significant incidental finding ("S" modifier) were also noted. We evaluated calcium scoring accuracy in patients in whom a cardiac or calcium scoring CT was performed within 1 year of the LCS CT. For the first LCS CT in all patients, we evaluated whether a stress test was performed within 6 months and whether a new statin prescription was written within 90 days of the LCS CT. Patients were stratified by atherosclerotic cardiovascular disease (ASCVD) risk group, used in a multivariable regression analysis for new statin prescriptions.
RESULTS: Eight thousand nine hundred eighty-seven patients underwent screening. In 117 patients who had a paired cardiac CT, scores were concordant in 65 (56%), and LCS CTs did not mention or underestimated calcifications in 40 (34%). Reporting of coronary artery calcifications led to new statin prescriptions, with OR of 1.8 for calcifications without S modifier and 4.4 for calcifications with S modifier. Reporting of coronary artery calcification with S modifier led to subsequent stress testing in 141/1582 (9%) of patients.
CONCLUSION: Coronary calcifications are frequently not mentioned or underestimated at LCS CT. Reporting of coronary calcifications leads to new statin prescriptions, and radiologists should consider reporting these to allow for a risk-benefit discussion with the patient's physician.
引用
- Hammer, Byrne, Blankstein, et al. Reporting and Outcomes of Coronary Calcification on Lung Cancer Screening CT. Acad Radiol. 2022. PMID: 36460581. doi:10.1016/j.acra.2022.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。